logo

Indian News

Share

foreignpopulations-sept19.jpg Home to 51 million migrants, the United States is hosting the largest number of international migrant populations in the world, a new UN report says. It is also one of the top three countries towards which most migrant journeys are taking place. The other top migrant destinations are Germany and Saudi Arabia. The latest data on the world's migrant population were released by the United Nation's

usappleimportduty-sept19.jpg In the wake of India's steep hike in import duty of U.S. apples hitting the farmers hard, a top Republican Congressman has appealed to the Trump administration to press the Indian government to reduce the tariff to the "pre-retaliatory rates." In a letter sent to U.S. Trade Representative Robert Lighthizer, Rep Dan Newhouse sought to elevate Washington apple access in India by decreasing the tari

brain-sept19.jpg Popular mobile games can provide useful information about the user's cognitive function, a new study done by researchers at the University of Kent reveals.

wave-sept19.jpg Shares of Wave Life Sciences Ltd. (WVE) are down over 55% from their 52-week high of $56 recorded on September 24, 2018.

pharmadown-sept18.jpg The following are some of the healthcare stocks that posted the biggest percentage decline on Wednesday.

pharmaup-sept18.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharma-041917_18sep19.jpg Today's Daily Dose brings you news about Bankruptcy filing of Sienna Biopharma; the first approval under FDA's Project Orbis, and public offering of Translate Bio.

pharmadown-sept17.jpg The following are some of the healthcare stocks that posted the biggest percentage decline on Tuesday.

pharmaup-sept17.jpg The following are some of today's top gainers in the pharma/biotech sector.

alzheimers-sept17.jpg Tai-Yen Chen, a chemist at the University of Houston is investigating the link between copper protein molecules in the brain cells and neurodegenerative diseases like Alzheimer's.

pharma-050317_17sep19.jpg Today's Daily Dose brings you news about Acceleron Pharma pulling the plug on facioscapulohumeral muscular dystrophy trial; Aclaris Therapeutics' THWART-2 trial results; the $150 million investment by HealthCare Royalty Partners in Karyopharm and the upcoming regulatory catalyst of Seattle Genetics.

pharmadown-sept16.jpg The following are some of the healthcare stocks that posted the biggest percentage decline on Monday.

pharmaup-sept16.jpg The following are some of today's top gainers in the pharma/biotech sector.

alzheimers-sept16.jpg A new study done by researchers from the University of California San Diego School of Medicine suggests that how quickly a person's pupil dilates while taking cognitive tests may reflect the increased risk of Alzheimer's disease.

biotechipo-sept13.jpg Mountain View, California-based IGM Biosciences is a biotechnology company developing engineered IgM antibodies for the treatment of cancer patients. Immunoglobulin M (IgM) is a class of antibody naturally produced by the human immune system.

Follow RTT